Lantheus EV/EBIT LNTH

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2016.

Today, Oct 23, 2026: 20.6×
10-year median: 16.2×
Against its 10-year history: 70th; percentile: 0 is its lowest day, 100 its highest
10-year range: 7.4× to 499×
Peer median: 30.9×

Lantheus' EV/EBIT is 20.6× as of Oct 23, 2026.

That is above its ten-year median of 16.2×, higher than on 70% of days in the last ten years.

Over that time it ranged from 7.4× in Sep 2025 to 499× in Apr 2021.

The median for 10 diagnostics and research stocks of a similar size is 30.9×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	20.6×	12.5×	23.9×
2025	12.9×	7.4×	15.2×
2024	12.7×	7.7×	24.0×
2023	23.0×	18.8×	204×
2022	19.8×	19.7×	71.1×
2021	427×	89.4×	499×
2020	82.4×	10.5×	89.6×
2019	16.3×	13.5×	19.4×
2018	13.0×	12.7×	19.8×
2017	17.7×	9.5×	19.2×
2016	9.7×	7.8×	10.5×

Against its peers

Companies in Medical - Diagnostics & Research nearest Lantheus' size, closest first, today.

Company	EV/EBIT
LNTHLantheus	20.6×
BLLNBillionToOne	107×
CAICaris Life Sciences	56.4×
BIOBio-Rad Laboratories	40.2×
VCYTVeracyte	27.2×
CDNACareDx	29.3×
RVTYRevvity	46.0×
MEDPMedpace	31.4×
LHLabcorp	21.6×
DGXQuest Diagnostics	19.5×
MTDMettler-Toledo International	30.5×
Peer median	30.9×

Where Lantheus ranks

#4of 25Diagnostics and research stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Lantheus

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.